Welcome to our dedicated page for Cantaloupe SEC filings (Ticker: CTLPP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cantaloupe, Inc. filings document the company’s completed merger with a 365 Retail Markets affiliate and the resulting corporate-status transition. The 8-K record covers the merger closing, termination and repayment of obligations under a credit agreement, material agreements, capital-structure matters, and related event disclosures.
Form 25 filings from Nasdaq document removal from listing and withdrawal of registration under Section 12(b) for Cantaloupe common stock. Other disclosure categories tied to the issuer include shareholder voting matters, risk factors, operating and financial results, and security-structure information.
Gaurav Singal, Chief Technology Officer of Cantaloupe, Inc. (CTLP), exercised and sold shares on 09/18/2025. He exercised 200,000 stock options with an exercise price of $3.27 per share, received the underlying common stock and immediately sold 200,000 shares at a weighted-average price of $10.63 per share. After these transactions he directly beneficially owns 40,533 shares. The exercised options were granted October 22, 2022 and vested in three equal annual installments beginning October 27, 2022. The filing states the purchase prices for the sale ranged from $10.6257 to $10.6325 and that the reporting person will provide details on request.
Cantaloupe, Inc. reports that its planned merger with 365 Retail Markets has triggered a “Second Request” for additional information from the U.S. Federal Trade Commission under the Hart-Scott-Rodino Act. This Second Request extends the regulatory waiting period until 30 days after both companies substantially comply with the information requests, adding time and complexity to the antitrust review.
The companies state they will continue cooperating with the FTC in its review of the merger. Assuming they receive required HSR clearance and all other closing conditions in the merger agreement are satisfied or waived in a timely manner, they currently expect to complete the merger in the first half of calendar year 2026. The filing also highlights extensive risks that could delay, alter, or prevent the transaction, including regulatory approvals, financing, integration challenges, potential termination and related fees, and broader economic and legal uncertainties.